Related Experiment Video
Updated: Aug 13, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
Hypnotherapy and IBS: Implicit, long-term stress memory in the ENS?
N Császár-Nagy1,2, I Bókkon2,3
1National University of Public Services, Budapest, Hungary.
Early life conditions and stress-induced memories may contribute to Irritable Bowel Syndrome (IBS). Hypnosis shows promise in alleviating IBS symptoms and associated mood disorders by accessing unconscious brain processes.
Area of Science:
- Neurogastroenterology
- Psychosomatic Medicine
- Epigenetics
Background:
- Irritable Bowel Syndrome (IBS) is increasingly linked to psychiatric and mood disorders.
- Early life conditions (prenatal to early-age) may play a crucial role in IBS development.
- Subthreshold mental disorders (SMDs) are potential contributors to various diseases, including IBS.
Purpose of the Study:
- To explore the hypothesis that stress-induced implicit memories, persisting via epigenetic processes in the enteric nervous system (ENS), contribute to IBS.
- To review the efficacy of hypnosis in managing IBS and related conditions.
Main Methods:
- Literature review examining the connection between early life factors, stress, memory, epigenetics, and IBS.
- Analysis of studies investigating the impact of hypnosis on IBS symptoms and psychological well-being.
Main Results:
- Stress-induced implicit memories, potentially mediated by epigenetic changes in the ENS, are hypothesized to be key in IBS onset and maintenance.
- Hypnosis has demonstrated significant benefits in improving core IBS symptoms, as well as non-colonic symptoms like anxiety and depression.
- Hypnosis also enhances quality of life and cognitive function in IBS patients.
Conclusions:
- The association between IBS and mental health disorders may stem from fundamental early-life and stress-related mechanisms.
- Epigenetic modifications in the ENS could preserve stress-induced memories, contributing to IBS.
- Hypnosis offers a therapeutic avenue for IBS by potentially accessing and modulating unconscious brain processes.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

